Kenneth A Bauer
Overview
Explore the profile of Kenneth A Bauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
4470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Al-Samkari H, Gupta S, Leaf R, Wang W, Rosovsky R, Brenner S, et al.
Ann Intern Med
. 2021 Jan;
174(5):622-632.
PMID: 33493012
Background: Hypercoagulability may be a key mechanism of death in patients with coronavirus disease 2019 (COVID-19). Objective: To evaluate the incidence of venous thromboembolism (VTE) and major bleeding in critically...
12.
Chiasakul T, Bauer K
Hematology Am Soc Hematol Educ Program
. 2020 Dec;
2020(1):612-618.
PMID: 33275702
Although anticoagulation remains the mainstay of treatment of acute venous thromboembolism (VTE), the use of thrombolytic agents or thrombectomy is required to immediately restore blood flow to thrombosed vessels. Nevertheless,...
13.
Darzi A, Repp A, Spencer F, Morsi R, Charide R, Etxeandia-Ikobaltzeta I, et al.
Blood Adv
. 2020 Oct;
4(19):4929-4944.
PMID: 33049056
Multiple risk-assessment models (RAMs) for venous thromboembolism (VTE) in hospitalized medical patients have been developed. To inform the 2018 American Society of Hematology (ASH) guidelines on VTE, we conducted an...
14.
Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird W, et al.
Blood
. 2020 Aug;
136(11):1342-1346.
PMID: 32766883
Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state with a high incidence of thrombotic events during hospitalization; however, data examining rates of thrombosis after discharge are limited. We...
15.
Patell R, Bogue T, Bindal P, Koshy A, Merrill M, Aird W, et al.
J Thromb Haemost
. 2020 Jul;
18(9):2349-2357.
PMID: 32692862
Background: Coronavirus disease-2019 (COVID-19) is a recognized prothrombotic state. Patients hospitalized with active cancer are predisposed to thrombosis but whether active cancer further amplifies thrombotic risk with COVID-19 is not...
16.
Patell R, Khan A, Bogue T, Merrill M, Koshy A, Bindal P, et al.
Am J Hematol
. 2020 Jul;
95(10):E295-E296.
PMID: 32658337
No abstract available.
17.
Gupta A, Madhavan M, Sehgal K, Nair N, Mahajan S, Sehrawat T, et al.
Nat Med
. 2020 Jul;
26(7):1017-1032.
PMID: 32651579
Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary...
18.
Zwicker J, Roopkumar J, Puligandla M, Schlechter B, Sharda A, Peereboom D, et al.
Blood Adv
. 2020 May;
4(10):2254-2260.
PMID: 32442298
Hospitalized patients with cancer are at an increased risk of developing venous thromboembolism (VTE). The recommendation for routine pharmacologic thromboprophylaxis in hospitalized patients with cancer to prevent VTE is based...
19.
Carroll B, Beyer S, Mehegan T, Dicks A, Pribish A, Locke A, et al.
Am J Med
. 2020 May;
133(11):1313-1321.e6.
PMID: 32416175
Background: Optimal management of acute pulmonary embolism requires expertise offered by multiple subspecialties. As such, pulmonary embolism response teams (PERTs) have increased in prevalence, but the institutional consequences of a...
20.
Kanjee Z, Bauer K, Breu A, Burns R
Ann Intern Med
. 2020 Apr;
172(7):484-491.
PMID: 32252085
Venous thromboembolism (VTE), which includes both deep venous thrombosis and pulmonary embolism, is a common and potentially fatal condition. Medical inpatients are at high risk for VTE because of immobility...